Tenderwize
Zurück zur Suche

Open House Discount Contracts for Amifampridin (ATC N07XX05)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Amifampridin, ATC N07XX05

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

50 / 100

Komplexität

20 / 100

Risikofaktoren

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Amifampridin (ATC N07XX05) to be supplied to the AOK Rheinland-Pfalz/Saarland.
  • Standardized contract terms; no negotiations.
Vollständige Zusammenfassung anzeigen

This is a non-exclusive open-house procedure for pharmaceutical discount contracts for the active ingredient Amifampridin (ATC N07XX05), organized by AOK Rheinland-Pfalz/Saarland. The procedure allows any interested pharmaceutical company to enter into standardized discount agreements without competitive selection. Contracts run up to 24 months from the earliest start date (01.05.2025) and can be terminated automatically if the buyer awards exclusive contracts. The notice is published voluntarily for transparency and is not subject to EU procurement law despite using the standard form.

Risiken

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Pharmaceutical companies must be authorized to market Amifampridin in Germany.
  • Drugs must be approved and marketable in Germany, proven by Lauer-Taxe listing or AMIce database extracts.

Administrative

  • Physical submission of signed contract documents; electronic submission not allowed.

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Contracts for Amifampridin (ATC N07XX05)

Non-exclusive discount contracts for Amifampridin with standardized terms. No negotiations, no exclusivity. Contracts end at the latest 24 months after the first contract start (01.05.2025), regardless of individual start dates. The buyer may replace these contracts with exclusive contracts at any time, causing automatic termination.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Frist

Deadline Feb 28, 2027

Vergabedetails

Veröffentlichungsdatum
12 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
164018-2025

Dokumente (1)

Ähnliche Ausschreibungen